???We are pleased that the core value of POTELLIGENT Technology has been recognized by a global pharmaceutical company such as Pfizer, and are excited to work together with Pfizer on their innovative antibody research pipelines,??? said Dr. Yasunori Yamaguchi, president and CEO of BioWa.